A recent study has demonstrated that in a mouse model of BCR-ABL oncogene-dependent chronic granulocytic leukemia CML, the disease induces an inflammatory response in the gut. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.